髓系急变期慢性髓性白血病中异质性白血病干细胞
本文探讨慢性髓性白血病(CML)从慢性期向髓系急变期(BP-CML)转化过程中,额外突变在造血层级中的获得位置、造血层级改变及白血病增殖干细胞(LSC)的细胞身份。研究发现髓系BP-CML中具有正常祖细胞免疫表型的群体扩增且患者间存在差异,系列移植证实功能性LSC存在于多个具有正常祖细胞及干细胞免疫表型的群体中,多色荧光原位杂交检测到17号染色体细胞遗传学异常的序贯获得与BP-CML转化相关并在所有功能性LSC区室中以相同频率检出。
要点
- 髓系BP-CML中具有正常祖细胞免疫表型的细胞群体扩增,且扩增模式在患者间存在异质性。
- 系列移植证实功能性LSC存在于多个具有正常祖细胞及干细胞免疫表型的细胞群体中。
- 17号染色体细胞遗传学异常序贯获得与BP-CML转化相关,在所有功能性LSC区室中检出频率相同。
核心结论
- 髓系BP-CML中功能性LSC分布于多个具有正常祖细胞及干细胞免疫表型的细胞群体,有效的髓系BP-CML新疗法可能需要靶向所有这些LSC群体。
研究设计与样本
- 研究采用免疫表型分析、免疫缺陷小鼠系列移植及多色荧光原位杂交,对髓系BP-CML患者的LSC群体及细胞遗传学异常获得进行探究。
主要发现
- 髓系BP-CML中具有正常祖细胞免疫表型的群体扩增,且扩增群体在患者间存在差异。
- 系列移植证实功能性LSC存在于多个具有正常祖细胞及干细胞免疫表型的群体中。
- 多色荧光原位杂交检测到17号染色体细胞遗传学异常的序贯获得与BP-CML转化相关,并在所有功能性LSC区室中以相同频率检出。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic myeloid leukemia (CML) is an excellent model of the multistep processes in cancer. Initiating BCR-ABL mutations are required for the initial phase of the disease (chronic phase, CP-CML). Some CP-CML patients acquire additional mutation(s) that transforms CP-CML to poor prognosis, hard to treat, acute myeloid or lymphoid leukemia or blast phase CML (BP-CML). It is unclear where in the hemopoietic hierarchy additional mutations are acquired in BP-CML, how the hemopoietic hierarchy is altered as a consequence, and the cellular identity of the resulting leukemia-propagating stem cell (LSC) populations. Here, we show that myeloid BP-CML is associated with expanded populations that have the immunophenotype of normal progenitor populations that vary between patients. Serial transplantation in immunodeficient mice demonstrated functional LSCs reside in multiple populations with the immunophenotype of normal progenitor as well as stem cells. Multicolor fluorescence in situ hybridization detected serial acquisition of cytogenetic abnormalities of chromosome 17, associated with transformation to BP-CML, that is detected with equal frequency in all functional LSC compartments. New effective myeloid BP-CML therapies will likely have to target all these LSC populations.
引用
- Kinstrie R, Karamitros D, Goardon N, et al. Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia. Blood Adv. 2016. PMID: 29296933. doi:10.1182/bloodadvances.2016000810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。